Trend of Death and Years of Life Lost Caused by Lung Cancer in Handan, 2017-2023
Nianzhen FANG, Yang ZHAO, Yang YANG

TL;DR
This study analyzes lung cancer death trends and life loss in Handan from 2017 to 2023, showing a decline in mortality and reduced impact on life expectancy.
Contribution
The study provides gender- and age-specific insights into lung cancer mortality trends and life loss in Handan, China.
Findings
Lung cancer standardized mortality rate decreased by 7.10% annually (AAPC=-7.10%, P<0.01).
Potential years of life lost (PYLL) due to lung cancer totaled 134,219.75 person-years.
Fulfillment index increased with age, indicating higher mortality impact in older populations.
Abstract
背景与目的 肺癌位居我国癌症死亡的首位,严重损害居民的生命健康。通过分析邯郸市2017至2023年肺癌死亡趋势及其导致的寿命损失情况,为防治策略的制定提供数据支撑。方法 收集2017至2023年邯郸市因肺癌导致的死亡资料,应用Excel 2010、SPSS 26.0和Joinpoint 4.9.0.0软件分析肺癌死亡率、平均年度变化百分比(average annual percentage change, AAPC)、去死因期望寿命(cause eliminated life expectancy, CELE)、去死因期望寿命增长年(potential gains in life expectancy, PGLEs)、Fulfillment指数、潜在减寿年数(potential years of life lost, PYLL)、潜在减寿率(potential years of life lost rate, PYLLR)、标化潜在减寿率(standardized potential years of life lost rate, SPYLLR)等指标。结果 2017至2023年邯郸市肺癌标化死亡率呈下降趋势(AAPC=-7.10%, P<0.01)。肺癌CELE增长了2.49岁(AAPC=0.48%, P<0.05);寿命损失率下降21.43%(AAPC=-4.61%, P<0.05)。2017至2023年肺癌的Fulfillment指数随着年龄的增长而增加。2017至2023年邯郸市因肺癌导致的PYLL为134,219.75人年,PYLLR为2.03‰,标化潜在减寿年数(standardized potential years of life lost, SPYLL)为98,735.63人年,SPYLLR为1.49‰,历年PYLLR和SPYLLR均呈下降趋势(AAPC=-6.34%和-9.34%,P均<0.01)。结论…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Treatments and Mutations · Cardiovascular Health and Risk Factors · Multiple and Secondary Primary Cancers
